lapatinib

Date：2021-12-20      Categories：Related Application Product

post date:	dec 19,2021
expiry date:	jun 17,2022
detailed description:	cas no. :231277-92-2 lapatinib 231277-92-2

cas registry number:	231277-92-2
synonyms:	;4-quinazolinamine, n-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-;n-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]quinazolin-4-amine;n-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-quinazolinamine;n-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-amine;lapatinib base;
molecular formula:	c29h26clfn4o4s
molecular weight:	581.0575
molecular structure: